Haemonetics Corp

Haemonetics Corp (HAE) Price Prediction & Forecast

$103.960

-1.029 (-0.99%)At close

Price Predictions

1-Day Price Prediction
+3.11%
1-Week Prediction
+8.58%
1-Month Prediction
2026 Prediction
2030 Prediction

Open in app to unlock longer-horizon forecasts.

Loading chart…

HAE Prediction & Forecast by Similar Chart Analysis

Alphio's HAE stock price prediction model matches the current Haemonetics Corp tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $107.19 (+3.11%). The 1-week path is $112.88 (+8.58%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Should I Buy Haemonetics Corp Stock?

Haemonetics Corp is a good buy right now due to its strong recent performance, with a 5.6% year-on-year revenue growth reported in Q2, and an adjusted EPS of $1.14, exceeding expectations by 5.8%. The current price of $103.96 is below the analyst price targets, which range from $100 to $119, suggesting significant upside potential. However, the recent net income drop to -20.15 million in Q4 poses a risk that investors should monitor closely.

HAE stock price ended at $103.96 on Friday, after losing -0.99%

Haemonetics Corp (HAE) last closed at $103.96, losing -0.99%. These facts feed the 1-day and 1-week HAE price prediction above.

Analyst Consensus

Haemonetics Corp (HAE): 3 buy, 5 hold, 1 sell. Outlook: Hold.

Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.

Strong sellSellNeutralBuyStrong buy
Buy
Sell
1
Buy
3

Forecast Drivers

Haemonetics Corp (HAE) forecast drivers combine similar chart patterns, seasonality, and moving averages.

Similar patterns

Positive

Bullish

Seasonality

Negative

Bearish

SMA 20

Positive

Bullish

SMA 200

Positive

Bullish

Similar Chart Patterns

Stocks whose recent price path most closely matches HAE, ranked by similarity.

Seasonality analysis for HAE

Historically the probability of a positive August return for HAE is 39.68%. December offers the highest probability of a positive month at 55.81%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.

Loading chart…

10-year price projections for HAE

MonthMin PriceAvg PriceMax PricePotential ROI
Aug 2026$53.75$66.30$72.55-36.23%
Sep 2026$77.43$79.91$86.34-23.13%
Oct 2026$71.72$79.91$87.07-23.13%
Nov 2026$51.21$61.51$62.22-40.83%
Dec 2026$64.77$78.90$80.27-24.10%

In 2026, Haemonetics Corp (HAE) is projected to range from $51.21 to $87.07.

Haemonetics Corp 2026 monthly forecast

Aug 2026 HAE forecast
Potential ROI: -36.23%

In Aug 2026, Haemonetics Corp is projected to average $66.30, with a low of $53.75 and high of $72.55.

Sep 2026 HAE forecast
Potential ROI: -23.13%

In Sep 2026, Haemonetics Corp is projected to average $79.91, with a low of $77.43 and high of $86.34.

Oct 2026 HAE forecast
Potential ROI: -23.13%

In Oct 2026, Haemonetics Corp is projected to average $79.91, with a low of $71.72 and high of $87.07.

Nov 2026 HAE forecast
Potential ROI: -40.83%

In Nov 2026, Haemonetics Corp is projected to average $61.51, with a low of $51.21 and high of $62.22.

Dec 2026 HAE forecast
Potential ROI: -24.10%

In Dec 2026, Haemonetics Corp is projected to average $78.90, with a low of $64.77 and high of $80.27.

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Get Started